Plena
Plena is a holding company based in Canada with a focus on large-scale production of high-grade medical cannabis.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
Plena Global Holdings Inc. operates as a business-to-business (B2B) producer and supplier of medical-grade cannabis. The company was established in 2017 with the goal of making high-quality medical cannabis accessible to patients globally. Headquartered in Victoria, Canada, Plena Global has strategically positioned its cultivation and production operations in South America to leverage optimal growing climates and lower production costs.
A key development in the company's history was the 2019 merger with Econnabis, a Colombian cannabis company founded by Mauricio Krausz. This move solidified its presence in Latin America and combined entrepreneurial vision with a global strategy. The firm serves a client base of licensed producers, pharmaceutical companies, narcotic manufacturers, and distributors across the world, providing them with the necessary raw materials to create cannabis-based products for patients. The business model is centered on a vertically integrated operation, managing everything from seed genetics to final shipment to ensure quality control and supply chain reliability for its partners.
Plena Global's core offering consists of medical-grade cannabis raw materials, including oils, concentrates, and flower. The company boasts a genetic bank with over 500 varietals and employs advanced cultivation techniques, including big data analytics for yield acceleration. A significant milestone was achieved in June 2019 with the first successful harvest in Colombia and the first shipment of CBD isolate to Canada. By December 2019, the company had commenced commercial shipments to Europe. Further solidifying its market position, its Colombian subsidiary, Econnabis, became the first in Latin America to receive the CUMCS IMC-G.A.P. certification in May 2022, a critical standard for medicinal cannabis production.
Keywords: medical cannabis, B2B cannabis supplier, cannabis cultivation, cannabis extraction, Colombian cannabis, pharmaceutical grade cannabis, CBD isolate, cannabis genetics, cannabis export, vertically integrated cannabis, Econnabis, Mauricio Krausz, medical marijuana, cannabis raw materials, agricultural technology, South American cannabis, cannabis supply chain, GACP, CUMCS certified, European cannabis market